<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03952897</url>
  </required_header>
  <id_info>
    <org_study_id>EO-BALNEO-19</org_study_id>
    <nct_id>NCT03952897</nct_id>
  </id_info>
  <brief_title>Quality of Life Related to Health in Spa Users</brief_title>
  <official_title>Observational Study for the Assessment of Quality of Life Related to Health in Users of the Spa of Fitero (Navarra).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Castilla-La Mancha</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Castilla-La Mancha</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypothesis: The spa therapy treatment could improve health-related quality of life (HRQOL) in
      subjects with knee and/or hip osteoarthritis, and patients with rheumatoid arthritis.

      Main objective: Analyze if HRQOL in patients with knee and/or hip osteoarthritis, and
      patients with rheumatoid arthritis is modified by spa therapy treatment in the spa of Fitero
      (Spain).

      Design: Prospective observational study Participants: Fitero's spa users aged between 45-80
      years old, diagnosed with knee and/or hip osteoarthritis, and also with rheumatoid arthritis.
      At least 40 patients of each type will be included in the study. Participants must be
      receiving a treatment of at least ten days.

      Main Variable: The scores obtained in the Euroqol5Dimensions-5Levels questionnaire (EQ-5D-5L)
      (for all subjects), the Western Ontario MacMaster Universities Osteoarthritis Index (WOMAC)
      questionnaire, for subjects with knee and/or hip osteoarthritis, and the Health Assessment
      Questionnaire (HAQ), for subjects with rheumatoid arthritis.

      Other variables: sociodemographic, anthropometric, clinics, and related with spa treatment.

      Follow-up duration: 9 months.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 1, 2018</start_date>
  <completion_date type="Anticipated">December 1, 2019</completion_date>
  <primary_completion_date type="Actual">March 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>HAQ (Health Assessment Questionnaire)-Disability of rheumatic patients</measure>
    <time_frame>From 1st March 2019 to 1st December 2019</time_frame>
    <description>Health Assessment Questionnaire (HAQ) assays the disability of rheumatic patients to carry out daily life activities. The questionary consists on 20 daily life questions, grouped in 8 areas, each one containing two or three questions related to daily life activities. Each question is scored from 0-3. 0 means &quot;done without difficulties&quot; (no disability), 3 score is &quot;impossible to do&quot; (completely disabled). The average of all responses is done. Average scores from 0-1 represent &quot;mild to moderate difficulty&quot;, 1-2 means &quot;moderate to severe disability&quot;, 3-2 indicates &quot;severe to very severe disability&quot;.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>WOMAC</measure>
    <time_frame>From 1st March 2019 to 1st December 2019</time_frame>
    <description>Western Ontario MacMaster Universities Osteoarthritis Index (WOMAC)</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Knee Osteoarthritis</condition>
  <condition>Hip Osteoarthritis</condition>
  <condition>Rheumatoid Arthritis</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>Subjects treated with balneotherapy for 10 days, previously diagnosed with knee and/or hip osteoarthritis, and subjects previously diagnosed with rheumatoid arthritis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>balneotherapy</intervention_name>
    <description>10 days of balneotherapy with immersion techniques using Fitero spa water.</description>
    <arm_group_label>Group 1</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Users of Fitero spa
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosed arthrosis of knee or hip and/or rheumatoid arthrosis

          -  balneotherapy treatment of at least 10 days.

          -  physically and mentally able to complete questionnaires

        Exclusion Criteria:

          -  have followed a balneotherapy treatment in the six previous month
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Inés Martínez-Galán, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Castilla-La Mancha</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universidad de Castilla-La Mancha</name>
      <address>
        <city>Toledo</city>
        <zip>45122</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 7, 2019</study_first_submitted>
  <study_first_submitted_qc>May 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 16, 2019</study_first_posted>
  <last_update_submitted>May 22, 2019</last_update_submitted>
  <last_update_submitted_qc>May 22, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>knee osteoarthritis</keyword>
  <keyword>rheumatoid arthritis</keyword>
  <keyword>balneology</keyword>
  <keyword>hip balneology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
    <mesh_term>Osteoarthritis, Hip</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

